Shares of Inovio Pharmaceuticals fell by a staggering 11.02% to $11.46 at 14:21 EST on Tuesday, after three consecutive sessions in a row of losses. NASDAQ Composite is sliding 1.65% to $13,309.70, following last session’s downward trend, This seems, so far, an all-around negative trend trading session today.

Inovio Pharmaceuticals’s last close was $12.88, 194.85% under its 52-week high of $33.79.

Inovio Pharmaceuticals’s Sales

Inovio Pharmaceuticals’s sales growth is 297.8% for the ongoing quarter and a decline by 50.3% for the next. The company’s growth estimates for the current quarter and the next is 42.1% and 30.8%, respectively.

Inovio Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth declined by 72.8%, now sitting on 2.11M for the twelve trailing months.


Inovio Pharmaceuticals’s last day, last week, and last month’s average volatility was 7.45%, 6.63%, and 9.08%, respectively.

Inovio Pharmaceuticals’s last day, last week, and last month’s high and low average amplitude percentage was 8.42%, 10.11%, and 14.57%, respectively.

Inovio Pharmaceuticals’s Stock Yearly Top and Bottom Value

Inovio Pharmaceuticals’s stock is valued at $11.46 at 14:21 EST, way below its 52-week high of $33.79 and way above its 52-week low of $3.60.

Inovio Pharmaceuticals’s Moving Average

Inovio Pharmaceuticals’s worth is under its 50-day moving average of $11.69 and under its 200-day moving average of $11.95.


Please enter your comment!
Please enter your name here